Skip to content

Net margin at other companies

Bausch Health Companies logo
Bausch Health CompaniesBHC
-1.9%-0.9pp
Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
-17.6%-103pp
PTH
Pelthos Therapeutics Inc.PTHS
-186.2%
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
-13.9%-6.6pp
HRO
HarrowHROW
-19.8%+18.0pp
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
37.1%+0.2pp

Other financials

Income statement

See full
Revenue$16.0M+21.5%
Gross profit$9.7M+16.7%
Operating income-$1.5M+55.1%
Net income-$2.2M+45.2%
EPS (diluted)-$0.08+55.6%

Balance sheet

See full
Cash & equivalents$27.2M+29.2%
Total debt$25.5M+1.2%
Total equity$30.8M+43.1%
Total assets$91.5M+7.7%

Cash flow

See full
Operating cash flow$2.9M+203%
CapEx$3.8M
Free cash flow-$6.0M

Valuation

See full
Market cap$194.94M+20.9%
Enterprise value$193.19M+16.2%
P/S+0.2×

Profitability

See full
Gross margin65.4%-1.0pp
Operating margin-9.8%
FCF margin-43%

Returns & leverage

See full
Return on equity-36.6%
Debt / equity0.8×-0.3×
Current ratio1.7×+0.4×

Where this comes from

Calculated from Journey Medical Corporation’s reported figures.

Based on trailing twelve months.

The official record: Journey Medical Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Journey Medical Corporation's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Journey Medical Corporation's net margin?
Journey Medical Corporation (DERM) reported net margin of -14.8% in Q1 2026.
What is the long-term trend for Journey Medical Corporation's net margin?
Over 3 years (2021 to 2025), Journey Medical Corporation's net margin has grown at a -35.8% compound annual growth rate (CAGR), from -69.7% to -18.5%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.